Scaling domestic data collection to meet global requirements is a little more complicated that some may think, said Ashish Kalgaonkar, senior director, global transparency reporting, Eli Lilly and Company, at the 2012 West Coast Life Sciences Meeting Management Forum. “The perception is that we should be able to do this easily, like credit-card companies do, but it is much more complicated for pharma.” That’s because you can’t just take information from a ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Tracking Global Physician Spend , you'll get exclusive access to a large archive of premium content.

Already registered? here.